Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

B. E. Sands; W. J. Sandborn; R. Panaccione; C. D. O'Brien; H. Zhang; J. Johanns; O. J. Adedokun; K. Li; L. Peyrin-Biroulet; G. Van Assche; S. Danese; S. Targan; M. T. Abreu; T. Hisamatsu; P. Szapary; C. Marano; Marieke Pierik; UNIFI Study Grp

doi:10.1056/NEJMoa1900750

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

B. E. Sands^*, W. J. Sandborn, R. Panaccione, C. D. O'Brien, H. Zhang, J. Johanns, O. J. Adedokun, K. Li, L. Peyrin-Biroulet, G. Van Assche, S. Danese, S. Targan, M. T. Abreu, T. Hisamatsu, P. Szapary, C. Marano, Marieke Pierik, UNIFI Study Grp

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1201-1214
Number of pages	14
Journal	New England Journal of Medicine
Volume	381
Issue number	13
DOIs	https://doi.org/10.1056/NEJMoa1900750
Publication status	Published - 26 Sep 2019

Keywords

ACTIVITY INDEXES
INFLIXIMAB
INFECTIONS
EFFICACY

Access to Document

10.1056/NEJMoa1900750

Cite this

Sands, B. E., Sandborn, W. J., Panaccione, R., O'Brien, C. D., Zhang, H., Johanns, J., Adedokun, O. J., Li, K., Peyrin-Biroulet, L., Van Assche, G., Danese, S., Targan, S., Abreu, M. T., Hisamatsu, T., Szapary, P., Marano, C., Pierik, M., & UNIFI Study Grp (2019). Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis. New England Journal of Medicine, 381(13), 1201-1214. https://doi.org/10.1056/NEJMoa1900750

Sands, B. E. ; Sandborn, W. J. ; Panaccione, R. ; O'Brien, C. D. ; Zhang, H. ; Johanns, J. ; Adedokun, O. J. ; Li, K. ; Peyrin-Biroulet, L. ; Van Assche, G. ; Danese, S. ; Targan, S. ; Abreu, M. T. ; Hisamatsu, T. ; Szapary, P. ; Marano, C. ; Pierik, Marieke ; UNIFI Study Grp. / Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis. In: New England Journal of Medicine. 2019 ; Vol. 381, No. 13. pp. 1201-1214.

@article{2509dd2686024c0383c96659c8935674,

title = "Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis",

keywords = "ACTIVITY INDEXES, INFLIXIMAB, INFECTIONS, EFFICACY",

author = "Sands, {B. E.} and Sandborn, {W. J.} and R. Panaccione and O'Brien, {C. D.} and H. Zhang and J. Johanns and Adedokun, {O. J.} and K. Li and L. Peyrin-Biroulet and {Van Assche}, G. and S. Danese and S. Targan and Abreu, {M. T.} and T. Hisamatsu and P. Szapary and C. Marano and Marieke Pierik and {UNIFI Study Grp}",

year = "2019",

month = sep,

day = "26",

doi = "10.1056/NEJMoa1900750",

language = "English",

volume = "381",

pages = "1201--1214",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "MASSACHUSETTS MEDICAL SOCIETY",

number = "13",

}

Sands, BE, Sandborn, WJ, Panaccione, R, O'Brien, CD, Zhang, H, Johanns, J, Adedokun, OJ, Li, K, Peyrin-Biroulet, L, Van Assche, G, Danese, S, Targan, S, Abreu, MT, Hisamatsu, T, Szapary, P, Marano, C, Pierik, M & UNIFI Study Grp 2019, 'Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis', New England Journal of Medicine, vol. 381, no. 13, pp. 1201-1214. https://doi.org/10.1056/NEJMoa1900750

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis. / Sands, B. E.; Sandborn, W. J.; Panaccione, R.; O'Brien, C. D.; Zhang, H.; Johanns, J.; Adedokun, O. J.; Li, K.; Peyrin-Biroulet, L.; Van Assche, G.; Danese, S.; Targan, S.; Abreu, M. T.; Hisamatsu, T.; Szapary, P.; Marano, C.; Pierik, Marieke; UNIFI Study Grp.

In: New England Journal of Medicine, Vol. 381, No. 13, 26.09.2019, p. 1201-1214.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

AU - Sands, B. E.

AU - Sandborn, W. J.

AU - Panaccione, R.

AU - O'Brien, C. D.

AU - Zhang, H.

AU - Johanns, J.

AU - Adedokun, O. J.

AU - Li, K.

AU - Peyrin-Biroulet, L.

AU - Van Assche, G.

AU - Danese, S.

AU - Targan, S.

AU - Abreu, M. T.

AU - Hisamatsu, T.

AU - Szapary, P.

AU - Marano, C.

AU - Pierik, Marieke

AU - UNIFI Study Grp

PY - 2019/9/26

Y1 - 2019/9/26

KW - ACTIVITY INDEXES

KW - INFLIXIMAB

KW - INFECTIONS

KW - EFFICACY

U2 - 10.1056/NEJMoa1900750

DO - 10.1056/NEJMoa1900750

M3 - Article

VL - 381

SP - 1201

EP - 1214

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 13

ER -